AICIS 2022 - Aluminium in antiperspirants and deodorants
The Australian Industrial Chemicals Introduction Scheme evaluated aluminium salts used in antiperspirants and deodorants as a public human-health risk assessment. The report does not contain new product testing, but it summarizes SCCS concentration and exposure data for deodorant and antiperspirant formulations. This page records the finished-product aluminium context and exposure assumptions without treating the report as a market survey.
Key numbers
- Evaluation identity:
Use of Aluminium in Antiperspirants, AICIS evaluation statementEVA00100, dated22 December 2022. - Evaluation scope: the assessment covers aluminium salts listed on the Australian Inventory of Industrial Chemicals and focuses on their use in antiperspirants and deodorants; worker risks were previously assessed under NICNAS IMAP.
- SCCS 2014 aluminium chlorohydrate formulation levels:
38%in aerosol formulations,14.5%in roll-on formulations, and21%in stick formulations, equivalent to9.5% Al,3.6% Al, and5.2% Al, respectively. A later supporting-information section reports the roll-on equivalent as3.61% Al. - Industry survey summary: based on data from a
2016industry survey, total aluminium concentration in a range of deodorant and antiperspirant products was3.24-7.7%. - SCCS 2022 Table 1 aluminium-salt concentrations in cosmetic products (
Max conc. %;Mean conc. %): sulfuric acid, aluminium salt (3:2)6.25;5.1; aluminium chloride hydroxide (Al2Cl(OH)5)25.5;18.5; aluminium chloride, basic30.9;21.3; aluminium zirconium chloride hydroxide10.2;10.2; aluminium chloride (AlCl3)12;11.1; aluminium chloride hexahydrate12;11.1; potassium alum dodecahydrate6.25;5.1. - SCCS 2022 Table 2 aluminium concentrations in deodorants and antiperspirants (
Max aluminium conc %;Mean aluminium conc %): deo roll on - gel6.18;1.7; deo roll on - roll on5.63;1.45; deo roll on - stick7.73;1.05; deo spray - anti perspirant3.24;0.32; deo spray - pump4.88;1.17. - Absorption assumptions: oral bioavailability is estimated at
0.3%via drinking water and0.1%via food. Dermal bioavailability from a recent study was0.00052%; with aluminium found in faeces (0.0014%), overall bioavailable aluminium was0.00192%. The report says95%of the dose remained on the skin and did not penetrate the body. - Risk-assessment point of departure: with a NOAEL of
30 mg/kg bw/dayfrom a neurodevelopmental toxicity study in rats, systemic exposure at the NOAEL was calculated as180 µg Al /kg bw/day. - Dermal SED values: at
0.00192%dermal bioavailability, SED was0.0265 µg Al/kg bw/dayfor non-spray formulations and0.0204 µg Al/kg bw/dayfor spray formulations. At0.00052%dermal bioavailability, SED was0.007 µg Al/kg bw/dayfor non-spray formulations and0.006 µg Al/kg bw/dayfor spray formulations. - Inhalation SED values: SCCS 2020 estimates were
0.00781 µg/kg bw/dayfor respirable particles in deep lung,0.00234 µg/kg bw/dayfor respirable particles deposited in the upper respiratory tract, and0.000432 µg/kg bw/dayfor non-respirable particles. SCCS 2022 estimated0.256 µg/kg bw/dayfor antiperspirant-spray inhalation using conservative assumptions of3%lung uptake and100%inhalation of released spray particles. - Margin-of-safety values copied from the source: dermal MOS at
0.00192%bioavailability was6792for non-spray and8823for spray formulations; dermal MOS at0.00052%bioavailability was25714for non-spray and30000for spray formulations. Inhalation MOS values were23047,76923, and416667for the SCCS 2020 particle fractions, while the SCCS 2022 conservative spray-inhalation MOS was703.
Methods (brief)
AICIS conducted a public human-health risk assessment for aluminium salts in antiperspirants and deodorants using prior NICNAS IMAP assessments, SCCS opinions, RIVM/VKM exposure evaluations, and industry-supplied SCCS 2022 concentration data. The report is a regulatory evaluation, not a primary laboratory occurrence study: it does not report product sampling locations, raw sample IDs, analytical instruments, LOD/LOQ values, CRM recoveries, or a new concentration dataset generated by AICIS. Concentration values are retained only as the SCCS/industry formulation context printed in the report.
Speciation: the source evaluates aluminium salts and reports aluminium as Al concentration or aluminium-salt percentage. It does not report arsenic, mercury, chromium species, or any other HMTc analyte species.
Implications
Certification (HMTc): This is A-tier regulatory and exposure-context evidence for the deodorants product category, especially antiperspirants and aluminium-salt formulations. It can support deodorant/antiperspirant routing and aluminium exposure narrative, but downstream pooling should distinguish its secondary SCCS concentration tables from primary product-occurrence surveys.
Courses: The report is useful for teaching the distinction between formulation percentage, finished-product aluminium percentage, dermal/inhalation exposure estimates, and occurrence sampling. It also shows why aluminium salts in deodorants should be kept as aluminium context rather than collapsed into unrelated metal species.
App: The source can support an Australian regulatory-context card for antiperspirant aluminium exposure. It should not be used for brand ranking, HMTc threshold comparison, or claims about products not covered by the source.
Wiki pages this source may touch
Verification notes
- PDF text was extracted with
pdftotext -layoutto/tmp/mfk_june8_aluminium_antiperspirants_statement.txt. The title block, subject/evaluation-scope pages, summary of use, Tables 1-2, human-exposure section, and risk-characterisation section were checked against this page. - No DOI is printed in the extracted report. Identity checks before creation found no existing
wiki/sources/aicis2022-aluminium-antiperspirants-evaluation.md, no title orEVA00100source-page hit, and no raw-handle hit forMFK_use-of-aluminium-in-antiperspirants-evaluation-sta. - Numbers are copied in the source’s own units (
%,µg Al/kg bw/day,µg/kg bw/day,mg/kg bw/day) and were not converted. The source’s3.6% Alversus3.61% Alroll-on equivalent is preserved as a source-internal precision difference rather than normalized. - Speciation: this page uses aluminium/Al only. The report does not provide iAs, tAs, MeHg, tHg, Cr(VI), or total Cr occurrence data.
- Brand firewall: the report uses formulation/product categories and an anonymized industry survey; no brand-linked values are reported here.
- Evidence tier:
Abecause this is an official AICIS regulatory evaluation. It is not primary occurrence evidence because AICIS did not generate the concentration data. - Routing: product slug
deodorantsand metal slugaluminumappear in the taxonomy snapshot. No closed ingredient slug is appropriate for the aluminium-salt group, soingredientsis left empty rather than inventing a salt-specific slug.npm run evidence:source-routesexited 0, generated onedeodorantsproduct route, left the source absent fromrouting_unresolved.csv, and recorded only the expected nonblocking empty-ingredients advisory inrouting_malformed.csv.
Page history
The five most recent substantive edits to this page. The full version history lives in git; when DOI minting comes online (see schema docs), each entry below will also link to a version-pinned DataCite DOI.
| Commit | Date | Description |
|---|---|---|
| 4039d20 | 2026-06-10 | scope: broaden ingest to the full upstream+downstream literature (marine, atmospheric, attribution, exposure, toxicology) — inclusion is the default |